Verified peer comparison

Recursion Pharmaceuticals vs AbCellera Biologics Financial Comparison

Direct answer

Recursion Pharmaceuticals and AbCellera Biologics are compared on the same basis.

The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage

Get free Recursion Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Recursion Pharmaceuticals Revenue
74,681,000 USD
AbCellera Biologics Revenue
75,128,000 USD
Recursion Pharmaceuticals Operating income
-648,132,000 USD
AbCellera Biologics Operating income
-217,103,000 USD